Back to Results
First PageMeta Content
Thrombocytosis / Eli Lilly and Company / Ketones / Drug rehabilitation / Polycythemia vera / Hydroxycarbamide / Essential thrombocytosis / Methadone / Plateletpheresis / Medicine / Chemistry / Hematopathology


___________________ CONTRAINDICATIONS ___________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing infor
Add to Reading List

Document Date: 2014-12-04 17:30:23

Open Document

File Size: 509,63 KB

Share Result on Facebook

Company

SUSPECTED ADVERSE REACTIONS / Incyte Corporation / /

Currency

pence / /

Event

Product Issues / /

IndustryTerm

magnetic resonance imaging / food / /

MedicalCondition

post-essential thrombocythemia myelofibrosis / polycythemia vera / Patients developing anemia / disease / post-polycythemia vera myelofibrosis / headache / Carcinogenesis / Neutropenia / Thrombocytopenia / Serious infections / Non-Melanoma Skin Cancer / primary myelofibrosis / phlebotomy-associated anemia / Polycythemia Vera A / Infection / end stage renal disease / dizziness / Anemia / Myelofibrosis / thrombocytopenia / gradual tapering / high-risk myelofibrosis / /

MedicalTreatment

Platelet transfusions / tube feeding / Dialysis / blood transfusions / /

Organization

OR ANC / _______________DOSAGE AND ADMINISTRATION / FDA / /

Person

Starting Dose / /

/

Product

hydroxyurea / itraconazole / ketoconazole / clarithromycin / Fluconazole / Suspend / response / /

Technology

Pharmacokinetics / magnetic resonance imaging / tomography / Pharmacodynamics / MRI / Dialysis / /

URL

www.fda.gov/medwatch / /

SocialTag